2. Diagnosis and Investigations
Pedagogy: This lesson uses pattern-recognition and red-flag identification — the critical safety-netting skills that prevent missed diagnoses and ensure timely referral.
Learning Objectives
- List the key differential diagnoses of menopausal symptoms: thyroid disease, PCOS, hypothalamic amenorrhoea, hyperprolactinaemia
- Identify the red flags that mandate urgent investigation: postmenopausal bleeding, unscheduled bleeding on HRT
- Apply the BMS 2024 risk-stratified approach to unscheduled bleeding on HRT
- State referral criteria for secondary care
Key Facts
Differential Diagnosis
| Condition | Shared Features with Menopause | Distinguishing Features | Key Investigation |
|---|---|---|---|
| Hypothyroidism | Fatigue, weight gain, mood changes, menstrual irregularity | Cold intolerance, constipation, bradycardia, dry skin | TSH, free T4 |
| Hyperthyroidism | Heat intolerance (mimics VMS), anxiety, palpitations, menstrual irregularity | Weight loss, tremor, tachycardia, exophthalmos | TSH, free T4 |
| Hyperprolactinaemia | Amenorrhoea, low libido | Galactorrhoea, visual field defects (macro-adenoma) | Serum prolactin |
| PCOS | Oligomenorrhoea | Androgen excess (acne, hirsutism), ↑ LH/FSH ratio, ↑ testosterone, ↑ AMH | Testosterone, LH, FSH, AMH, USS pelvis |
| Hypothalamic amenorrhoea | Amenorrhoea, low mood | Stress, over-exercise, low BMI, low oestradiol with LOW FSH/LH | FSH, LH, oestradiol (all low) |
| Pregnancy | Amenorrhoea, nausea | Should always be excluded in premenopausal amenorrhoea | β-hCG |
Red Flags Requiring Urgent Investigation
Postmenopausal bleeding (PMB): Any vaginal bleeding occurring ≥12 months after the last menstrual period in a woman not on HRT must be investigated urgently via the suspected cancer pathway (2-week wait). Endometrial cancer must be excluded (2).
Unscheduled bleeding on HRT: The BMS/RCOG 2024 guideline introduced a risk-stratified approach. If no clinical or scan-based risk factors: adjust progestogen for 6 months. If risk factors present or bleeding persists beyond 6 months: urgent TVS within 6 weeks or USCP referral (3).
Clinical Pearl
Always exclude pregnancy in any premenopausal woman with amenorrhoea — even if she 'can't possibly be pregnant.' This is a medicolegal imperative.
Clinical Pearl
Hypothalamic amenorrhoea has LOW FSH and LOW oestradiol (the brain is suppressing the HPO axis). Menopause has HIGH FSH and LOW oestradiol (the ovary has failed). This distinction is fundamental.
Case-Based Examples
Case 1: 48-year-old with heat intolerance and anxiety
Presentation: A 48-year-old presents with episodes of feeling hot, anxiety, palpitations, and menstrual irregularity. She has lost 4 kg unintentionally over 3 months. She assumes it's 'the menopause.'
Question: What differential diagnosis must you consider and how would you investigate?
Model Answer: Hyperthyroidism mimics menopausal VMS closely — heat intolerance, anxiety, palpitations, menstrual irregularity. The unintentional weight loss is a red flag against menopause (which is typically associated with weight gain). Check TSH and free T4 urgently. If TSH is suppressed with elevated T4: diagnosis of hyperthyroidism, refer to endocrinology. If TSH is normal: menopausal symptoms are more likely, and can be managed as per standard pathway.
Case 2: 57-year-old on continuous combined HRT with new bleeding
Presentation: A 57-year-old has been on continuous combined HRT (Evorel Conti) for 4 years with amenorrhoea. She presents with a 3-week history of light vaginal spotting. BMI 32, diabetes, and her mother had endometrial cancer at age 62.
Question: Apply the BMS/RCOG 2024 risk-stratified approach.
Model Answer: This patient has multiple risk factors for endometrial cancer: BMI ≥30 (minor risk factor), diabetes (minor), and first-degree relative with endometrial cancer (assess if Lynch syndrome — potential major risk factor). The new bleeding after a spell of amenorrhoea on ccHRT is concerning. Per BMS/RCOG 2024: with risk factors present, offer urgent suspected cancer pathway (USCP) referral — do not simply adjust HRT. While awaiting assessment, consider adjusting progestogen dose (may need to increase) or stopping HRT temporarily. TVS to assess endometrial thickness (>4 mm on ccHRT warrants endometrial sampling).
Self-Assessment Questions
PLAB/MLA Distinguishing hypothalamic amenorrhoea from menopause
A 34-year-old distance runner with BMI 17 has amenorrhoea and fatigue. FSH is 2 IU/L, oestradiol is low. What is the most likely diagnosis?
A. Premature ovarian insufficiency
B. Hypothalamic amenorrhoea
C. Menopause
D. PCOS
Answer: B. Low FSH + low oestradiol + low BMI + excessive exercise = hypothalamic amenorrhoea. In POI/menopause, FSH would be elevated (>25 IU/L).
MRCGP Unscheduled bleeding on HRT — when to investigate
A 54-year-old started ccHRT 4 months ago and has persistent light spotting. No risk factors for endometrial cancer. BMI 25. What is the most appropriate next step?
A. Urgent 2-week wait cancer referral
B. Immediate hysteroscopy
C. Adjust the progestogen component and reassess at 6 months total
D. Stop HRT immediately
Answer: C. BMS/RCOG 2024: If bleeding occurs within 6 months of starting HRT and no endometrial cancer risk factors are present, adjust progestogen/HRT for 6 months total before investigating. Automatic 2WW is no longer recommended for all cases.
Professor The BMS/RCOG paradigm shift — clinical implications
The BMS/RCOG 2024 guideline on unscheduled bleeding replaced automatic 2WW referral with risk-stratified management. Evaluate the potential benefits and risks of this paradigm shift for primary care.
A. It increases cancer detection rates by referring all patients
B. It reduces unnecessary referrals for benign pathology while maintaining safety through risk stratification, but requires GPs to confidently identify endometrial cancer risk factors
C. It removes all responsibility from primary care
D. It is identical to the previous guideline
Answer: B. The paradigm shift reduces the burden on gynaecology services (up to 40% of HRT users have unscheduled bleeding, with 38–66% showing atrophic endometrium). The risk-stratified approach requires GPs to identify major risk factors (BMI ≥40, Lynch/Cowden syndrome, prolonged unopposed oestrogen) and minor factors (BMI 30–39, diabetes, inadequate progestogen duration). Benefits: faster access for truly high-risk women, reduced anxiety for low-risk women, fewer unnecessary procedures. Risks: depends on GP confidence in risk stratification; requires access to TVS within 6 weeks; potential for missed cases if risk factors are not systematically assessed. Education and clinical decision support tools are essential for safe implementation.
Take-Away Messages
- Always exclude thyroid disease and pregnancy before attributing symptoms to menopause
- Hypothalamic amenorrhoea: LOW FSH + LOW oestradiol; menopause: HIGH FSH + LOW oestradiol
- Postmenopausal bleeding (≥12 months after LMP, not on HRT) = urgent 2WW referral
- Unscheduled bleeding on HRT: BMS/RCOG 2024 risk-stratified approach — not automatic 2WW for all
- Risk factors for endometrial cancer: BMI ≥40, Lynch syndrome, prolonged unopposed oestrogen, inadequate progestogen